The board of directors of virtual colonoscopy and contrast developer E-Z-EM has authorized the repurchase by the company of up to 300,000 shares of its common stock. Repurchased common shares will be added to the Lake Success, NY-based vendor’s treasury shares, and will be used to meet current and near-term stock requirements for benefit plans and other corporate purposes. E-Z-EM had over 10 million shares of common stock outstanding as of January 9, 2003, according to the firm.
By AuntMinnie.com staff writersMarch 7, 2003
Related Reading
E-Z-EM inks deal with SourceOne, February 17, 2003
E-Z-EM posts positive Q2, January 15, 2003
PointDx, E-Z-EM ink license agreement, January 2, 2003
E-Z-EM touts colon CAD for InnerviewGI, December 10, 2002
E-Z-EM completes recapitalization merger, October 22, 2002
Copyright © 2003 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
